Healthcare Stocks Among Worst Performers -- Healthcare Roundup

Dow Jones

04-16

Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.

Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.

J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.

Write to Paulo Trevisani at paulo.trevisani@wsj.com

(END) Dow Jones Newswires

April 15, 2025 17:01 ET (21:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2527047808"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527047808\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2527047808?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527047808","market":"hk","top_or_hot":-1,"title":"Healthcare Stocks Among Worst Performers -- Healthcare Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare Stocks Among Worst Performers -- Healthcare Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare Stocks Among Worst Performers -- Healthcare Roundup\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-04-16 05:01</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"綜合支持服務","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527047808","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527047808","pubTimestamp":1744750860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","HCSG":"医疗保健服务"},"translate_title":"医疗保健股是表现最差的股票之一——医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1},"content_text":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n\n\n  Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n\n\n  J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n\n\n \n\n\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 17:01 ET (21:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}